New active substance shows promise in treating acute sudden hearing loss

A research team led by MedUni Vienna has investigated AC102, a new active substance that offers hope of an effective treatment for acute sudden hearing loss. The latest results have been published in the scientific journal “Cell Death & Disease”.

Opentrons partners with Zymo Research to automate key microbiome chemistries on the Opentrons Flex™

Opentrons Labworks, Inc., a leader in lab automation and makers of accessible lab robotics and Zymo Research Corp, a life science reagent company, are collaborating to

June 19, 2023

Thrivelab Launches Affordable Virtual Menopause Care for Women

What You Should Know: – Thrivelab, a provider of hormone health services, is addressing the women’s health crisis by launching accessible and affordable virtual menopause

October 11, 2024

Bavarian Nordic’s chikungunya vaccine secures EMA fast-track – Pharmaceutical Technology

Share this article The EMA has already accepted a marketing application from Valneva under accelerated review for the disease. Image credit: Shutterstock/Iryna Mylinska. Hot on

February 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.